Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions. - Test2 - elhamkhani - TriplyDB

Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions.

Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions.

http://www.wikidata.org/entity/Q38542034

about

Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos.Enhancement of Immune Effector Functions by Modulating IgG's Intrinsic Affinity for Target Antigen Effect of heated naringenin on immunomodulatory properties and cellular antioxidant activity.Avelumab: combining immune checkpoint inhibition and antibody-dependent cytotoxicity.Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy.Innate immune cells for immunotherapy of autoimmune and cancer disorders.Dynamic Analysis of Human Natural Killer Cell Response at Single-Cell Resolution in B-Cell Non-Hodgkin Lymphoma.Restricted processing of CD16a/Fc γ receptor IIIa N-glycans from primary human NK cells impacts structure and function.Abnormal populations and functions of natural killer cells in patients with myelodysplastic syndromes.Tumor immunotherapy: New aspects of natural killer cells.Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming.Optimization of Large-Scale Expansion and Cryopreservation of Human Natural Killer Cells for Anti-Tumor Therapy

P2860

Q35963673-4B052FBD-0C1B-4E5F-AF30-35C70CCCA6FD Q36056627-D3ACE0AC-661E-4DC1-8655-C79BB2B22366 Q37372979-461CFC3E-A31E-43CD-B2A8-6A2F18821E65 Q38920328-1CF56988-DCB7-4A00-8096-B904827CD0F3 Q47156322-84744D01-2181-46C4-9C43-B005421DA9E9 Q48316500-C3BBE4D7-6113-46BF-8F45-DB6C6C473188 Q49237902-19C81297-7EC6-4296-A534-5A79E23F6481 Q50058989-927C28D4-5812-407B-9B93-182499431BDA Q52349555-940F9D85-134F-45EB-9CEB-216550D3409D Q55107050-A409B122-9D96-499D-ABB7-C205F637D90C Q55486099-4F148A66-A3E4-4F43-A101-77CCCB09114A Q58727819-F245CF90-0038-4AC9-B2A7-67FD12928732

P2860

Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions.

http://www.wikidata.org/entity/Q38542034

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions.

@en

type

label

Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions.

@en

prefLabel

Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions.

@en

P1433

Q38542034-53284BE9-F46B-4756-A7C4-050C5EF2D71B

P1476

Q38542034-70A0E8C3-4DF0-412F-AF3D-E8056B3AD858

P2093

Q38542034-8A22B75C-3838-41E8-9975-C4E96534708D

P2860

Q38542034-01176893-D7EC-409F-9DA8-E2779607086B

Q38542034-0411EE35-BE47-418B-8438-0743F65FC900

Q38542034-0493700B-1A06-415B-A423-115D6920D372

Q38542034-09E25C8D-634F-47C9-B82D-060FEEB707D1

Q38542034-0A973216-8B23-48B4-AC70-F37A600165FD

Q38542034-0B651E91-BCEC-4F8C-BDAD-8F490BA3F2EE

Q38542034-0BDD7F46-06F1-47C5-BB84-1914EE0B8380

Q38542034-0DA798F6-DF48-4791-B4C4-FB753CB3145C

Q38542034-0F3ACC65-906F-4B9D-8C16-A16A73C86427

Q38542034-103F2D3E-1FB8-4258-9671-36F4F85EF2EF

P304

Q38542034-2B71B4D5-E023-453D-B67C-E923BE7315F1

P31

Q38542034-7EAEC1A0-0664-428F-9986-FA4FAFF36366

P356

Q38542034-F36747B1-ECD8-4B2D-8F15-0A304C589832

P433

Q38542034-C31153D7-AA8C-4945-9732-DA1124D371CF

P478

Q38542034-46B76C6D-9D37-4D41-8162-B76620334F33

P50

Q38542034-3F2BB546-EE29-4930-B162-EA4E0FB68250

Q38542034-C24595E0-0BC9-407F-883C-219C1EA0D629

Q38542034-EEE26BDA-33B9-4DCE-8886-EC31825C762E

P577

Q38542034-4134380C-27D7-47D6-AE89-53F5C1775F30

P5875

Q38542034-EAE20C95-4C59-4F07-93B6-7FD4D4EEDACF

P698

Q38542034-0E951E01-7E36-432A-92E2-D23CBCE7343C

P356

JLB.5VMR0415-141R

P1433

Journal of Leukocyte Biology

P1476

Natural killer (NK) cells and anti-tumor therapeutic mAb: unexplored interactions

@en

P2093

Angela Santoni

http://www.w3.org/2001/XMLSchema#string

P2860

Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies

Rituximab: mechanism of action

Activation receptor-induced tolerance of mature NK cells in vivo requires signaling through the receptor and is reversible

The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity

Immune Checkpoint Blockade in Cancer Therapy

Natural killer cell biology: an update and future directions

Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics

Novel immunotherapies for hematologic malignancies

Killer immunoglobulin-like receptors and tumor immunity

Tumor antigen-specific monoclonal antibodies and induction of T-cell immunity

P304

87-96

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1189/JLB.5VMR0415-141R

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

Simone Battella

Gabriella Palmieri

M Christina Cox

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279729259

http://www.w3.org/2001/XMLSchema#string

P698

26136506

http://www.w3.org/2001/XMLSchema#string